Enhertu approved in the US as first tumour-agnostic HER2-directed therapy
Enhertu now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers
Enhertu now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers
Aurigene.AI is an end-to-end solution for small molecule drug discovery
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
The drug will target specific genetic mutations prevalent in certain types of cancers
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Subscribe To Our Newsletter & Stay Updated